BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28455832)

  • 1. Structure and Function of the Two-Component Cytotoxins of Staphylococcus aureus - Learnings for Designing Novel Therapeutics.
    Badarau A; Trstenjak N; Nagy E
    Adv Exp Med Biol; 2017; 966():15-35. PubMed ID: 28455832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH.
    Badarau A; Rouha H; Malafa S; Logan DT; Håkansson M; Stulik L; Dolezilkova I; Teubenbacher A; Gross K; Maierhofer B; Weber S; Jägerhofer M; Hoffman D; Nagy E
    J Biol Chem; 2015 Jan; 290(1):142-56. PubMed ID: 25371205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
    Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
    MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies.
    Rouha H; Weber S; Janesch P; Maierhofer B; Gross K; Dolezilkova I; Mirkina I; Visram ZC; Malafa S; Stulik L; Badarau A; Nagy E
    Virulence; 2018 Jan; 9(1):231-247. PubMed ID: 29099326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?
    Vandenesch F; Lina G; Henry T
    Front Cell Infect Microbiol; 2012; 2():12. PubMed ID: 22919604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus.
    Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL
    Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.
    Reyes-Robles T; Lubkin A; Alonzo F; Lacy DB; Torres VJ
    EMBO Rep; 2016 Mar; 17(3):428-40. PubMed ID: 26882549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective sensitization of human neutrophils to LukGH mediated cytotoxicity by Staphylococcus aureus and IL-8.
    Janesch P; Rouha H; Weber S; Malafa S; Gross K; Maierhofer B; Badarau A; Visram ZC; Stulik L; Nagy E
    J Infect; 2017 May; 74(5):473-483. PubMed ID: 28237625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity.
    Tromp AT; Van Gent M; Jansen JP; Scheepmaker LM; Velthuizen A; De Haas CJC; Van Kessel KPM; Bardoel BW; Boettcher M; McManus MT; Van Strijp JAG; Lebbink RJ; Haas PA; Spaan AN
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32041354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic landscapes on
    Kailasan S; Kant R; Noonan-Shueh M; Kanipakala T; Liao G; Shulenin S; Leung DW; Alm RA; Adhikari RP; Amarasinghe GK; Gross ML; Aman MJ
    MAbs; 2022; 14(1):2083467. PubMed ID: 35730685
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcal γ-hemolysins induce IL-4 production in murine basophils.
    Ogata A; Hayashi K; Kitano T; Onozaki K; Itoh S; Hida S
    Biochem Biophys Res Commun; 2022 Dec; 632():107-112. PubMed ID: 36206594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
    Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins.
    Pédelacq JD; Maveyraud L; Prévost G; Baba-Moussa L; González A; Courcelle E; Shepard W; Monteil H; Samama JP; Mourey L
    Structure; 1999 Mar; 7(3):277-87. PubMed ID: 10368297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.
    Tromp AT; Van Gent M; Abrial P; Martin A; Jansen JP; De Haas CJC; Van Kessel KPM; Bardoel BW; Kruse E; Bourdonnay E; Boettcher M; McManus MT; Day CJ; Jennings MP; Lina G; Vandenesch F; Van Strijp JAG; Lebbink RJ; Haas PA; Henry T; Spaan AN
    Nat Microbiol; 2018 Jun; 3(6):708-717. PubMed ID: 29736038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlatching of the stem domains in the Staphylococcus aureus pore-forming leukocidin LukAB influences toxin oligomerization.
    Ilmain JK; Perelman SS; Panepinto MC; Irnov I; Coudray N; Samhadaneh N; Pironti A; Ueberheide B; Ekiert DC; Bhabha G; Torres VJ
    J Biol Chem; 2023 Dec; 299(12):105321. PubMed ID: 37802313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice.
    Lubkin A; Lee WL; Alonzo F; Wang C; Aligo J; Keller M; Girgis NM; Reyes-Robles T; Chan R; O'Malley A; Buckley P; Vozhilla N; Vasquez MT; Su J; Sugiyama M; Yeung ST; Coffre M; Bajwa S; Chen E; Martin P; Kim SY; Loomis C; Worthen GS; Shopsin B; Khanna KM; Weinstock D; Lynch AS; Koralov SB; Loke P; Cadwell K; Torres VJ
    Cell Host Microbe; 2019 Mar; 25(3):463-470.e9. PubMed ID: 30799265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes.
    Ferreras M; Höper F; Dalla Serra M; Colin DA; Prévost G; Menestrina G
    Biochim Biophys Acta; 1998 Nov; 1414(1-2):108-26. PubMed ID: 9804914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin.
    Scherr TD; Hanke ML; Huang O; James DB; Horswill AR; Bayles KW; Fey PD; Torres VJ; Kielian T
    mBio; 2015 Aug; 6(4):. PubMed ID: 26307164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha- and gamma-hemolysins and leukocidin.
    Tomita T; Kamio Y
    Biosci Biotechnol Biochem; 1997 Apr; 61(4):565-72. PubMed ID: 9145511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biologic agents to neutralize the bicomponent leukocidins of
    Chan R; Buckley PT; O'Malley A; Sause WE; Alonzo F; Lubkin A; Boguslawski KM; Payne A; Fernandez J; Strohl WR; Whitaker B; Lynch AS; Torres VJ
    Sci Transl Med; 2019 Jan; 11(475):. PubMed ID: 30651319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.